Skip to main content
Premium Trial:

Request an Annual Quote

Aptus Genomics Appoints Former Shire Co-founder President

NEW YORK, Sept. 28 - Aptus Genomics, a biotech company that focuses on G-protein coupled receptor genes, has appointed Krystyna Belendiuk as president, the company said on Friday. 

"I am very pleased to have someone with Krystyna's knowledge and experience join the Aptus management team," Kevin Chance, founder and CEO of Aptus, said in a statement. 

Before joining Aptus, Belendiuk was co-founder, director, and senior vice president of Pharmavene, now known as Shire Laboratories.

Aptus, which in June moved its headquarters to Gaithersburg, Md., from Rockville, Md., reported in May that it raised $6.2 million in a round of financing. 

The company, founded in June 2000, is currently completing gene collection and will move to high-throughput functional assays and screening to be used for in-house drug discovery development and future partnership collaborations, Chance told GenomeWeb in May.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.